Characterizing the Heterogeneity of Primary Tumors and Advanced Disease in Intrahepatic CCA

William Jarnagin, MD, FACS, Memorial Sloan Kettering Cancer Center, discusses his recent study on characterizing the heterogeneity of intrahepatic cholangiocarcinoma (ICCA) and the concordance of oncogenic alterations between intrahepatic and extrahepatic disease.

Dr. Jarnagin also expands on what the study results mean for personalized treatment approaches, along with future research in relation to the study.